Cozaar Comp 100 mg/25 mg film-coated tablets

国家: 爱尔兰

语言: 英文

来源: HPRA (Health Products Regulatory Authority)

有效成分:

Losartan potassium; Hydrochlorothiazide

可用日期:

PCO Manufacturing Ltd.

ATC代码:

C09CA; C09CA01

INN（国际名称）:

Losartan potassium; Hydrochlorothiazide

剂量:

100/25 milligram(s)

药物剂型:

Film-coated tablet

处方类型:

Product subject to prescription which may be renewed (B)

治疗领域:

Angiotensin II antagonists, plain; losartan

授权状态:

Authorised

授权日期:

2008-02-08

资料单张

_ _
_ _
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
COZAAR
® COMP 50 MG/12.5 MG FILM-COATED TABLETS
COZAAR
®
COMP 100 MG/12.5 MG FILM-COATED TABLETS
COZAAR
® COMP 100 MG/25 MG FILM-COATED TABLETS
losartan potassium and hydrochlorothiazide
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor, pharmacist or
nurse.
•
This medicine has been prescribed for you only. Do not pass it on to
others.
It may harm them, even if their signs of illness are the same as
yours.
•
If you get any side effects, talk to your doctor, pharmacist, or
nurse. This includes any
possible side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Cozaar Comp is and what it is used for
2.
What you need to know before you take Cozaar Comp
3.
How to take Cozaar Comp
4.
Possible side effects
5.
How to store Cozaar Comp
6.
Contents of the pack and other information
1.
WHAT COZAAR COMP IS AND WHAT IT IS USED FOR
Cozaar Comp is a combination of an angiotensin II receptor antagonist
(losartan) and a
diuretic (hydrochlorothiazide). Angiotensin II is a substance produced
in the body which
binds to receptors in blood vessels, causing them to tighten. This
results in an increase in
blood pressure. Losartan prevents the binding of angiotensin II to
these receptors, causing
the blood vessels to relax which in turn lowers the blood pressure.
Hydrochlorothiazide
works by making the kidneys pass more water and salt. This also helps
to reduce blood
pressure.
Cozaar Comp is indicated for the treatment of essential hypertension
(high blood
pressure).
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE COZAAR COMP
DO NOT TAKE COZAAR COMP
•
if you are allergic to losartan, hydrochlorothiazide or to any of the
other ingredients of
this medicine (listed in section 6),
•
if you are allergic to other sulfonamide
‑
derived substances (e.g. other thiazides, som

产品特点

Health Products Regulatory Authority
04 July 2023
CRN00DNW6
Page 1 of 2
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Cozaar Comp 100 mg/25 mg film-coated tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 100mg of losartan potassium and 25mg of
hydrochlorothiazide (HCTZ) as the active ingredients.
Excipient(s) with known effect: Lactose Monohydrate
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film-coated Tablet
_Product imported from Italy, Hungary and France:_
'Cozaar' Comp is supplied as oval, yellow, film-coated tablets with
'747' on one side and plain on the other.
4 CLINICAL PARTICULARS
As per PA23198/001/003
5 PHARMACOLOGICAL PROPERTIES
As per PA23198/001/003
6 PHARMACEUTICAL PARTICULARS
6.1 LIST OF EXCIPIENTS
Hydroxypropyl cellulose (E463)
Hypromellose (E464)
Lactose monohydrate
Magnesium stearate (E572)
Microcrystalline cellulose (E460)
Pregelatinised starch
Titanium dioxide (E171)
Quinoline yellow aluminium lake (E104)
Carnauba wax (E903)
6.2 INCOMPATIBILITIES
Not applicable.
6.3 SHELF LIFE
The shelf-life expiry date of this product is the date shown on the
container and outer package of the product on the market in
the country of origin.
6.4 SPECIAL PRECAUTIONS FOR STORAGE
Do not store above 30°C. Store in the original package in order to
protect from light and moisture.
Health Products Regulatory Authority
04 July 2023
CRN00DNW6
Page 2 of 2
6.5 NATURE AND CONTENTS OF CONTAINER
White, opaque PVC/PE/PVDC blisters containing 28 tablets with
aluminium foil lidding.
6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR
WASTE MATERIALS DERIVED FROM SUCH MEDICINAL
PRODUCT AND OTHER HANDLING OF THE PRODUCT
No special requirements.
7 PARALLEL PRODUCT AUTHORISATION HOLDER
PCO Manufacturing Ltd.
Unit 10, Ashbourne Business Park
Rath
Ashbourne
Co. Meath
Ireland
8 PARALLEL PRODUCT AUTHORISATION NUMBER
PPA0465/109/002
9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
Date of First Authorisation: 8th February 2008
10 DATE OF R